Pfizer heart drug gains new licence in UK InPharm Pfizer's heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients with heart failure. Inspra (eplerenone) is already indicated to treat patients with heart failure after a recent heart attack, alongside standard ... Pfizer receives new UK approval for Inspra |
